CHS INC - CHSINC 7 1/2 PERP (CHSCL) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CHSCL • US12542R8034

25.795 USD
+0.03 (+0.1%)
Last: Feb 9, 2026, 08:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHSCL. CHSCL was compared to 88 industry peers in the Food Products industry. While CHSCL is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCL does not seem to be growing, but still is valued expensively. Finally CHSCL also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CHSCL had a positive cash flow from operations.
  • Each year in the past 5 years CHSCL has been profitable.
  • In the past 5 years CHSCL always reported a positive cash flow from operatings.
CHSCL Yearly Net Income VS EBIT VS OCF VS FCFCHSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • CHSCL has a better Return On Assets (3.17%) than 61.36% of its industry peers.
  • With a Return On Equity value of 5.40%, CHSCL perfoms like the industry average, outperforming 57.95% of the companies in the same industry.
  • CHSCL has a worse Return On Invested Capital (0.49%) than 60.23% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHSCL is significantly below the industry average of 27.75%.
Industry RankSector Rank
ROA 3.17%
ROE 5.4%
ROIC 0.49%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCL Yearly ROA, ROE, ROICCHSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of CHSCL (1.69%) is comparable to the rest of the industry.
  • CHSCL's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 0.26%, CHSCL is doing worse than 61.36% of the companies in the same industry.
  • CHSCL's Operating Margin has declined in the last couple of years.
  • CHSCL's Gross Margin of 3.21% is on the low side compared to the rest of the industry. CHSCL is outperformed by 84.09% of its industry peers.
  • CHSCL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.26%
PM (TTM) 1.69%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCL Yearly Profit, Operating, Gross MarginsCHSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCL is destroying value.
  • Compared to 1 year ago, CHSCL has a worse debt to assets ratio.
CHSCL Yearly Shares OutstandingCHSCL Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCL Yearly Total Debt VS Total AssetsCHSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • CHSCL has an Altman-Z score of 2.32. This is not the best score and indicates that CHSCL is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.32, CHSCL perfoms like the industry average, outperforming 53.41% of the companies in the same industry.
  • CHSCL has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • CHSCL's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. CHSCL outperforms 64.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACC0.09
WACC5.47%
CHSCL Yearly LT Debt VS Equity VS FCFCHSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • CHSCL has a Current Ratio of 1.53. This is a normal value and indicates that CHSCL is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CHSCL (1.53) is comparable to the rest of the industry.
  • CHSCL has a Quick Ratio of 1.53. This is a bad value and indicates that CHSCL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CHSCL has a Quick ratio (0.91) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.91
CHSCL Yearly Current Assets VS Current LiabilitesCHSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. Growth

3.1 Past

  • The Revenue has decreased by -9.68% in the past year.
  • CHSCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.54% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCL Yearly Revenue VS EstimatesCHSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCL Price Earnings VS Forward Price EarningsCHSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • CHSCL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHSCL is cheaper than 94.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.46
CHSCL Per share dataCHSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

  • CHSCL has a Yearly Dividend Yield of 7.30%, which is a nice return.
  • CHSCL's Dividend Yield is rather good when compared to the industry average which is at 2.22. CHSCL pays more dividend than 93.18% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, CHSCL pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.3%

5.2 History

  • CHSCL has paid a dividend for at least 10 years, which is a reliable track record.
  • CHSCL has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years9
CHSCL Yearly Dividends per shareCHSCL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 28.20% of the earnings are spent on dividend by CHSCL. This is a low number and sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCL Yearly Income VS Free CF VS DividendCHSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCL Dividend Payout.CHSCL Dividend Payout, showing the Payout Ratio.CHSCL Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 7 1/2 PERP

NASDAQ:CHSCL (2/9/2026, 8:00:01 PM)

25.795

+0.03 (+0.1%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06
Earnings (Next)03-31
Inst Owners11.23%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap316.50M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 7.3%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years9
Ex-Date03-17
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.5
P/B 0.03
P/tB 0.03
EV/EBITDA 2.46
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY200.88%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 5.4%
ROCE 0.67%
ROIC 0.49%
ROICexc 0.5%
ROICexgc 0.5%
OM 0.26%
PM (TTM) 1.69%
GM 3.21%
FCFM N/A
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 3.9
Cap/Depr 111.84%
Cap/Sales 2.05%
Interest Coverage 0.62
Cash Conversion 85.64%
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 0.91
Altman-Z 2.32
F-Score5
WACC5.47%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%

CHS INC - CHSINC 7 1/2 PERP / CHSCL FAQ

What is the fundamental rating for CHSCL stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCL.


Can you provide the valuation status for CHS INC - CHSINC 7 1/2 PERP?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7 1/2 PERP (CHSCL). This can be considered as Overvalued.


What is the profitability of CHSCL stock?

CHS INC - CHSINC 7 1/2 PERP (CHSCL) has a profitability rating of 4 / 10.


How sustainable is the dividend of CHS INC - CHSINC 7 1/2 PERP (CHSCL) stock?

The dividend rating of CHS INC - CHSINC 7 1/2 PERP (CHSCL) is 7 / 10 and the dividend payout ratio is 28.2%.